Medical cannabis group EMMAC forms research partnership with Hyris Ltd
Share:
PARIS (Reuters) - European medical cannabis company EMMAC announced on Monday a research partnership with UK biotechnology company Hyris Limited to develop a library of genetic profiles of existing cannabis varieties.Earlier this month, EMMAC bought French hemp-based and cannabis healthcare company GreenLeaf, as the legal use of cannabis for medicinal purposes steadily increases.Cannabis stocks have been a growing trend on world stock markets, particularly on the Toronto stock exchange after..